HLA Diagnostics 05 – High resolution, molecular HLA typing class I and II (444)
[HLA-Diagnostik 05 - Hochauflösende, molekulargenetische HLA-Typisierung Klasse I und II (444)]
EPTIS factsheet 160009 | Last revision 2023-10-23 | URL: https://www.eptis.bam.de/pts160009 https://www.eptis.bam.de/pts160009
| PT provider | |||||||||||||||||||||||||||||||||||||
| PT provider | INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories | ||||||||||||||||||||||||||||||||||||
| Based in | Germany | ||||||||||||||||||||||||||||||||||||
| Language(s) | German, English | ||||||||||||||||||||||||||||||||||||
| Remarks | The interdisciplinary, non-profit, scientific and medical association INSTAND e. V. is a reference institution for the quality control of medical laboratories. It is one of three reference institutions appointed by the German Medical Association and, thus, responsible for the organization of external quality assessment (EQA) schemes for quality control in medical laboratories. You can register for EQAs, submit your results as PDF via https://rv-online.instandev.de. This price applies exclusively to orders placed via INSTAND e.V. Prices and services may differ for orders placed via distributors. | ||||||||||||||||||||||||||||||||||||
| Keywords | |||||||||||||||||||||||||||||||||||||
| Product groups |
Human test material
|
||||||||||||||||||||||||||||||||||||
| Testing fields |
Medical analysis
|
||||||||||||||||||||||||||||||||||||
| Technical details | |||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
| Aims of the PT scheme | |||||||||||||||||||||||||||||||||||||
| Target group of participants | Molecular HLA typing class I and II in high resolution according to standards of the European Federation for Immunogenetics (EFI). The following loci may be reported: HLA-A,-B,-C,-DRB1,-DRB3/4/5,-DQA1,- DQB1,-DPA1 and -DPB1. In addition, HLA-B*57:01 associated with Abacavir hypersensitivity and HLA-DR epitopes associated with rheumatoid arthritis may be reported. It is not possible to report individual antigens, e.g. in the context of HLA disease associations (HLA-A29, HLA-B51, etc.) | ||||||||||||||||||||||||||||||||||||
| Linked to specific legislation / standards | |||||||||||||||||||||||||||||||||||||
| Additional, subsidiary aims | |||||||||||||||||||||||||||||||||||||
| Number of participants | <50 | ||||||||||||||||||||||||||||||||||||
| Accredited or otherwise reviewed by a 3rd party |
Accredited by DAkkS (Germany) on the basis of ISO/IEC 17043 German Bundesärztekammer (General medical Council) |
||||||||||||||||||||||||||||||||||||
| Operation is commissioned / requested by | German Bundesärztekammer (General medical Council) | ||||||||||||||||||||||||||||||||||||
| Fees and frequency | |||||||||||||||||||||||||||||||||||||
| Participation fee | 140 Euro | ||||||||||||||||||||||||||||||||||||
| Regularly operated | Yes (4 times per year) | ||||||||||||||||||||||||||||||||||||
| Year of first operation | Experience with operation of ILCs since 1968 | ||||||||||||||||||||||||||||||||||||
| Contact details of the PT provider | |||||||||||||||||||||||||||||||||||||
| Provider | Contact person | ||||||||||||||||||||||||||||||||||||
|
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
P.O.Box 250211, Ubierstrasse 20 40223 Düsseldorf Germany Phone: +49-211-159213-0 Fax: Web: http://www.instandev.de/ http://www.instandev.de/ |
Dr. rer. nat. Nathalie Weiss
Phone: +49-211-159213430 Fax: Email: weiss@instand-ev.de weiss@instand-ev.de |
||||||||||||||||||||||||||||||||||||